Atlas market file · Equity · United States
Metlife IncMET
- Last close
- 0.1676
- Change
- -0.95%
- 96-bar range
- 0.0943 – 0.2018
- As of
- 6 Aug 2026
Metlife Inc is a life insurance issuer listed as MET on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
MET
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 39 weekly closes (-61.40% over the window).
Source rail: Binance spot klines (MET/USDT). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for MET. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Atlas Pro artifact
MET Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
Atlas Pro entitlement required. The release gate runs again when you request the file.
MET public profile
Life insurance issuer. Metlife Inc is connected to current market context, cited company sources and its retained research file.
Metlife Inc trades as MET on NYSE. Metlife Inc (MET) has a latest verified close of 0.1676, down 0.95%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files MET under USA Stocks for browsing.
What changed for Metlife Inc today
MetLife Inc. (MET) reported $19.07B in revenue and $1.19B in net income for Q1 2026, with diluted EPS of $1.74 on 655.7M shares outstanding, according to its 10-Q filing. The insurer holds $22.69B in cash and $4.95B in short-term investments but faces liabilities of $715.41B against equity of $27.32B, raising questions about leverage in its insurance obligations.
As a provider of group benefits and small business insurance, MetLife’s operational reality hinges on underwriting discipline and investment income. Its recent 8-K filing highlighted 'preliminary variable investment income,' a vague teaser ahead of full earnings disclosure, suggesting sensitivity to market swings in its portfolio.
SEC filings reveal insider activity: the MetLife 401(k) Plan sold shares in two tranches (June 18 and 26), per Form 144 submissions. Meanwhile, a June 22 S-8 POS registration indicated shareholder approval for equity compensation plans, potentially diluting retail holders. No buyback announcements have offset this, despite $2.69B in operating cash flow.
Chart-wise, MET’s stock has traded in a $58-$63 range since April, per TradingView. Volume remains light, averaging 4M shares daily, reflecting institutional dominance. No material news has disrupted this pattern recently, leaving the stock in a low-volatility purgatory.
The lack of updated guidance post-Q1 earnings leaves analysts grasping at straws. MetLife’s next catalyst could come from its Q2 supplement or regulatory shifts in insurance capital requirements. Until then, the market will parse every 8-K like a horoscope.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
MET technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-29. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on MET
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep MET research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
MET FAQ
What is Metlife Inc (MET)?Metlife Inc (MET) has a latest verified close of 0.1676, down 0.95%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Metlife Inc (MET) has a latest verified close of 0.1676, down 0.95%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for MET?Metlife Inc (MET) has a latest verified close of 0.1676, down 0.95%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...
Metlife Inc (MET) has a latest verified close of 0.1676, down 0.95%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files MET under USA Stocks for browsing.
How often is the MET page updated?The MET public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The MET public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for MET?The MET file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:MET. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The MET file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:MET. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on MET?Yes. The workstation can open MET, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open MET, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this MET page investment advice?No. The MET page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The MET page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-07-30. Browse FreedomCore Atlas research notes →